DE3406837A1 - Arteriosklerose-arzneimittel und -prophylaktikum - Google Patents

Arteriosklerose-arzneimittel und -prophylaktikum

Info

Publication number
DE3406837A1
DE3406837A1 DE19843406837 DE3406837A DE3406837A1 DE 3406837 A1 DE3406837 A1 DE 3406837A1 DE 19843406837 DE19843406837 DE 19843406837 DE 3406837 A DE3406837 A DE 3406837A DE 3406837 A1 DE3406837 A1 DE 3406837A1
Authority
DE
Germany
Prior art keywords
diltiazem
treatment
medicament
arteriosclerosis
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19843406837
Other languages
German (de)
English (en)
Other versions
DE3406837C2 (enrdf_load_stackoverflow
Inventor
Hitoshi Tokio/Tokyo Iwasaki
Kazuyuki Urawa Saitama Kitamura
Takashi Kawagoe Saitama Morita
Azusa Minoh Osaka Okaniwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of DE3406837A1 publication Critical patent/DE3406837A1/de
Application granted granted Critical
Publication of DE3406837C2 publication Critical patent/DE3406837C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DE19843406837 1983-02-25 1984-02-24 Arteriosklerose-arzneimittel und -prophylaktikum Granted DE3406837A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58031515A JPS59157021A (ja) 1983-02-25 1983-02-25 動脈硬化症予防治療剤

Publications (2)

Publication Number Publication Date
DE3406837A1 true DE3406837A1 (de) 1984-08-30
DE3406837C2 DE3406837C2 (enrdf_load_stackoverflow) 1990-12-20

Family

ID=12333337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843406837 Granted DE3406837A1 (de) 1983-02-25 1984-02-24 Arteriosklerose-arzneimittel und -prophylaktikum

Country Status (12)

Country Link
JP (1) JPS59157021A (enrdf_load_stackoverflow)
BE (1) BE899000A (enrdf_load_stackoverflow)
CH (1) CH658389A5 (enrdf_load_stackoverflow)
DE (1) DE3406837A1 (enrdf_load_stackoverflow)
DK (1) DK163712C (enrdf_load_stackoverflow)
FR (1) FR2541577B1 (enrdf_load_stackoverflow)
GB (1) GB2135192B (enrdf_load_stackoverflow)
HK (1) HK45389A (enrdf_load_stackoverflow)
IT (1) IT1178863B (enrdf_load_stackoverflow)
NL (1) NL8400548A (enrdf_load_stackoverflow)
SE (1) SE8400971L (enrdf_load_stackoverflow)
SG (1) SG21189G (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
JPS63107925A (ja) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd 動脈硬化症予防・治療剤
JP2658783B2 (ja) * 1992-12-10 1997-09-30 田辺製薬株式会社 抗動脈硬化剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
GB1236467A (en) * 1967-10-28 1971-06-23 Tanabe Seiyaku Co Benzothiazepine derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Münchner Medizinische Wochenschrift, 123, 1981, S. 15-21 *
PSCHYREMBEL, W.: Klinisches Wörterbuch, 1982, S. 86-87 *

Also Published As

Publication number Publication date
SE8400971D0 (sv) 1984-02-22
DK103084D0 (da) 1984-02-24
JPS6358809B2 (enrdf_load_stackoverflow) 1988-11-17
SG21189G (en) 1990-01-26
DK163712B (da) 1992-03-30
SE8400971L (sv) 1984-08-26
IT1178863B (it) 1987-09-16
IT8467183A0 (it) 1984-02-24
DK163712C (da) 1992-08-31
NL8400548A (nl) 1984-09-17
FR2541577A1 (fr) 1984-08-31
DE3406837C2 (enrdf_load_stackoverflow) 1990-12-20
GB2135192A (en) 1984-08-30
CH658389A5 (de) 1986-11-14
BE899000A (fr) 1984-06-18
GB8405060D0 (en) 1984-04-04
IT8467183A1 (it) 1985-08-24
FR2541577B1 (fr) 1987-05-22
GB2135192B (en) 1986-10-22
HK45389A (en) 1989-06-16
DK103084A (da) 1984-08-26
JPS59157021A (ja) 1984-09-06

Similar Documents

Publication Publication Date Title
EP0241809B1 (de) Synergistische Kombination von Amantadin und Selegilin
DE69621756T2 (de) Betahydroxybuttersäure oder Acetoessigsäure oder deren Salze oder Ester zur Verwendung zur Verbesserung der Gehirnfunktion
DE2911670A1 (de) Arzneimittel zur therapeutischen behandlung von peripheren vaskularen erkrankungen
DE69811643T2 (de) Mischung primärer fettsäuren aus zuckerrohrwachs
AT389998B (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
DE3639378C2 (enrdf_load_stackoverflow)
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE2514335C3 (de) Oral zu verabreichendes Arzneimittel mit Antiplasmin-Inhibitorwirkung
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
EP0224810B1 (de) Antihypertensives Kombinationspräparat
DE2530862C2 (de) Verwendung von Uridin-5'-diphosphat zur Verhütung und Behandlung von Alkoholismus
DE3035494A1 (de) Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels
CH660556A5 (de) Therapeutische zubereitung zur behandlung von kardiovaskulaeren krankheiten.
DE69828390T2 (de) Antikrebs-zusammensetzung
DE69308762T2 (de) Behandlung des Muskulschwunds
DE60207442T2 (de) VERWENDUNG EINER KOMBINATIONSZUSAMMENSETZUNG BESTEHEND AUS PROPIONYL L-CARNITIN UND WEITEREn WIRKSTOFFEn ZUR BEHANDLUNG DER EREKTILEN DYSFUNKTION
DE69735892T2 (de) Heil-und vorbeugungsmittel für stomatitis
DE3406837C2 (enrdf_load_stackoverflow)
EP0207193A2 (de) Synergistische Kombination von Flupirtin und 4-Acetamido-phenol
DE69004529T2 (de) Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
DE2161588C3 (de) Mittel zur Behandlung von Hyperlipoproteinämien
DE69909395T2 (de) Zusammensetzung mit ketanserin und carnitin zur behandlung von crps
DE3419425A1 (de) Verwendung von d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5h)-on als arzneimittel zur bekaempfung der hypolipidaemie
DE3780702T2 (de) Verwendung von etodolac zur senkung des blutgehalts an harnsaeure.
DE69426317T2 (de) Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee